Neuroinflammatory Diseases

Neuroinflammatory diseases are a complex group of conditions that occur when the immune system attacks the body’s healthy cells. These include multiple sclerosis, acute disseminated encephalomyelitis, optic neuritis, neuromyelitis optica, and transverse myelitis. The exact causes of these disorders are not fully understood but involve a complex interplay of genetic and environmental factors.

Possible Clinical Signs:

Multiple Sclerosis

  • Blurred or double vision
  • Muscle weakness
  • Coordination and balance difficulties
  • Numbness or tingling
  • Speech problems
  • Excessive fatigue
  • Memory and concentration issues

Acute Disseminated Encephalomyelitis (ADEM)

  • Fever and headache
  • Behavioral changes, confusion, altered consciousness
  • Loss of strength and coordination
  • Vision problems
  • Seizures

Optic Neuritis

  • Sudden vision loss in one eye
  • Eye pain, especially with movement
  • Decreased color perception

Neuromyelitis Optica

  • Vision loss in one or both eyes
  • Muscle weakness and limb paralysis
  • Bladder and bowel control issues

Transverse Myelitis

  • Sudden weakness in legs or arms
  • Lower back pain
  • Numbness and tingling
  • Bladder and bowel dysfunction

Diagnosing and treating these conditions can be challenging. The process starts with a detailed assessment of symptoms and medical history, followed by laboratory tests (autoimmune markers, cerebrospinal fluid analysis, and antibody testing) and imaging studies such as brain or spinal MRI.

Treatment focuses on managing symptoms, slowing disease progression, and improving the patient’s quality of life. Anti-inflammatory therapy is used to reduce inflammation and regulate immune responses. It is essential for patients to have a personalized treatment plan tailored to their specific needs.

Our center participates in the National Program for Multiple Sclerosis, offering specialized care and support.

The impact of neuroinflammatory diseases on quality of life is significant, making emotional support from family and the community essential. Continuous education and awareness can help improve the lives of those affected.

  1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008 Oct 25;372(9648):1502-17. doi: 10.1016/S0140-6736(08)61620-7. PMID: 18970977.
  2. Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 2015 Apr;14(4):406-19. doi: 10.1016/S1474-4422(14)70305-9. PMID: 25792099.
  3. Lucchinetti CF, Kiers L, O’Duffy A, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997 Dec;49(6):1754-60. doi: 10.1212/WNL.49.6.1754. PMID: 9409338.
  4. Bradshaw MJ, Schneider-Gold C, Blackmore D, et al. Neuromyelitis optica spectrum disorder. J Neurol. 2018 Aug;265(8):1756-1764. doi: 10.1007/s00415-018-8888-4. PMID: 29651729.
  5. Klein R, Harris LA. Diagnosis and management of transverse myelitis. Pract Neurol. 2007 Dec;7(6):395-405. doi: 10.1136/jnnp.2007.139378. PMID: 18003752.

Additional Resources

    Additional information